IQVIA joins Veeva’s AI partner programs to streamline clinical trials

The collaboration connects a global CRO (contract research organization) with Veeva’s platform and AI (artificial intelligence) stack to speed study builds and data delivery.

Summary

IQVIA has joined Veeva’s technology and services partner programs as an AI partner, opening the door for IQVIA data and analytics to power Veeva’s applications and for sponsors to run trials on an integrated toolset. On the clinical side, IQVIA also joined Veeva’s CRO Clinical Data Partner program to use the Veeva Clinical Suite—including Veeva EDC (electronic data capture)—to accelerate database builds, study locks, and delivery of clean data. These moves build on the companies’ newly announced long-term partnerships. (Applied Clinical Trials Online)

What happened

• IQVIA joined Veeva’s Technology, AI, and Services Partner Programs, enabling IQVIA datasets and AI to enhance Veeva products and simplifying customer integrations across clinical and commercial workflows (Applied Clinical Trials; IQVIA partner page). (Applied Clinical Trials Online)
• IQVIA joined Veeva’s CRO Clinical Data Partner program so its teams can execute studies with Veeva Clinical Suite tools such as Veeva EDC, aimed at compressing timelines and improving data quality (IQVIA press release; PR Newswire). (IQVIA)
• The clinical and commercial agreements resolve prior disputes and formalize a long-term collaboration between the companies (PR Newswire). (PR Newswire)

Key numbers and dates

• Announced: August 18, 2025 (partnerships and dispute resolution); coverage and updates published today highlighting the AI partner status and clinical integration details (PR Newswire; Applied Clinical Trials). (PR Newswire)
• Program participation: Veeva Technology Alliance, AI Partner, Service Partner, and CRO Clinical Data Partner programs (IQVIA partner page). (IQVIA)

What to watch next

• Sponsor case studies showing faster study start-up, shorter database build times, and quicker locks under the combined model (IQVIA press release). (IQVIA)
• How AI-enabled matching and data curation flow into Veeva’s clinical apps and downstream analytics, including monitoring dashboards and data delivery to statisticians and safety teams (Applied Clinical Trials). (Applied Clinical Trials Online)

Why this matters for you

Sponsors and site teams gain a cleaner path to run studies on a single, connected stack—from protocol build to EDC and monitoring—without stitching tools together. Plain-English eligibility guides and site toolkits aligned to how AI screens patients can cut screen failures and shorten the journey from referral to consent.

Digital and data leaders will need to connect AI outputs to existing trial systems with secure data flows, human-in-the-loop reviews, and audit trails. Simple metrics—time to first site live, days to database lock, and data-query rates—will help prove impact while meeting privacy and validation requirements.

Sources: Applied Clinical Trials; IQVIA press release; PR Newswire; IQVIA partner page. (Applied Clinical Trials Online)